Our website use cookies to improve and personalize your experience and to display advertisements(if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, Youtube. By using the website, you consent to the use of cookies. We have updated our Privacy Policy. Please click on the button to check our Privacy Policy.

J&J unit to start mid-stage COVID-19 vaccine trials in Spain

Reading Time: < 1 minute

Johnson & Johnson’s Janssen unit will begin mid-stage trials of its COVID-19 vaccine in Spain on Monday, the programme’s lead investigator said.

Alberto Borobia said 190 people would take part in the country’s trials, which will take place in three hospitals and be concluded by Sept. 22.

The Spanish study is part of mid-stage, or Phase II, trials of the vaccine that are being carried out in three countries, also including the Netherlands and Germany. The trials in the three countries will last two months and include 550 participants in total. 

Related Posts

%d bloggers like this: